Satta T, Li L, Chalasani S, Hu X, Nkwocha J, Sharma K, et al. Dual mTORC1/2 Inhibition Synergistically Enhances AML Cell Death in Combination with the BCL2 Antagonist Venetoclax. Clin Cancer Res. 2023;29:1332-1343 pubmed publisher

Kohli J, Ge C, Fitsiou E, Doepner M, Brandenburg S, Faller W, et al. Targeting anti-apoptotic pathways eliminates senescent melanocytes and leads to nevi regression. Nat Commun. 2022;13:7923 pubmed publisher

Orzalli M, Prochera A, Payne L, Smith A, Garlick J, Kagan J. Virus-mediated inactivation of anti-apoptotic Bcl-2 family members promotes Gasdermin-E-dependent pyroptosis in barrier epithelial cells. Immunity. 2021;54:1447-1462.e5 pubmed publisher

Zhang H, Nakauchi Y, Köhnke T, Stafford M, Bottomly D, Thomas R, et al. Integrated analysis of patient samples identifies biomarkers for venetoclax efficacy and combination strategies in acute myeloid leukemia. Nat Cancer. 2020;1:826-839 pubmed publisher

Hong A, Guerriero J, Doshi M, Kynnap B, Kim W, Schinzel A, et al. MCL1 and DEDD Promote Urothelial Carcinoma Progression. Mol Cancer Res. 2019;17:1294-1304 pubmed publisher